28 April 2020

Dr. Kongkrapan Intarajang, CEO of GC, together with his executive team, present CoviClear, or the silver nanoparticle disinfection unit to help reduce the risk of COVID-19 transmission to Chulalongkorn Hospital, the Thai Red Cross Society

Share:

Dr. Kongkrapan Intarajang, Chief Executive Officer of GC, and his executive team presented CoviClear or the silver nanoparticle disinfection unit, which is designed to help lower the risk of contracting COVID-19 along with raw materials in producing two types of disinfectant liquid namely; triethanolamine (TEA) for which GC is the only manufacturer in Thailand, and Pharmaceutical-grade glycerine for use in CoviClear to Chulalongkorn Hospital, the Thai Red Cross Society in which the donation was received by Prof. Dr. Suttipong Wacharasindhu, Dean of the Faculty of Medicine, Chulalongkorn University, Assoc. Prof. Dr. Chanchai Sittipunt, Associate Dean for Planning and Development Department, and Asst. Prof. Dr. Nakarin Sirisabya, Assistant Dean for Planning and Development Department, Faculty of Medicine, Chulalongkorn University.

CoviClear is an innovation developed by GC that increases the disinfection and prevention of germs by releasing silver nanoparticles through a micron-sized nozzle in the form of a vapor. The vapor pairs the silver nanoparticles with viruses, bacteria and other diseases which a person carries, including on their clothing, killing them on contact without causing any harm.

News

News
01 October 2021
Thailand Sustainability Expo 2021 (TSX) ตอกย้ำความสำเร็จต่อเนื่องปีที่ 2 ชวนร่วมงานแบบ New Normal ในรูปแบบ Virtual Expo ยิ่งใหญ่ที่สุดของเมืองไทย พร้อมจัดเต็ม 11 วัน 30 กันยายน-10 ตุลาคม นี้
Read More
News
20 June 2020
The shared robot providing medical assistance at Somdej Phranangchaosirikit Hospital [Siam Rath]
Read More
News
09 April 2020
Mahidol University and GC join forces to engineer and develop Thailand’s first CoviClear to prevent the risk of COVID-19
Read More